FDA issues warning to controversial Houston cancer doctor
The Food and Drug Administration has issued a strongly worded warning letter to a controversial Houston physician, Stanislaw Burzynski, who was the subject of a USA TODAY investigation last month. Burzynski – hailed as a maverick by his fans but a snake oil salesman by mainstream doctors -- has long claimed to have dramatic success in hard-to-treat cancers, especially brainstem tumors that are usually considered fatal. According to the National Cancer Institute, however, Burzynski has never produced definitive proof that his drugs save lives by publishing a randomized, controlled trial in a peer-reviewed journal.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- Revenue Cycles Get a Boost from Simple JPEG Files
- Hospitals Likely to Outsource ICD-10 at Launch
- Anatomy of 3 Health System Rebranding Efforts